Intended for healthcare professionals

Observations The Washington Brief

When EMA and FDA decisions conflict: differences in patients or in regulation?

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5140 (Published 22 August 2013) Cite this as: BMJ 2013;347:f5140

Re: When EMA and FDA decisions conflict: differences in patients or in regulation?

The ostensible differences between the EMA (Europe) and the FDA (US) are superficial and trivial. In reality, these “differences” are a distinction without a difference, because both regulatory agencies have a consistently cozy relationship with Big Pharma, as evinced by the priciness of pharmaceuticals, the prevalence of polypharmacy, and a lucrative revolving door. To quote the Roman satirist Juvenal, “Who will protect us from our protecters?”

Competing interests: No competing interests

25 August 2013
Hugh Mann
Physician
Retired
Eagle Rock, MO, USA